To get from point A of a stem cell discovery to point B of a patient actually receiving a treatment based on that discovery is a long and non-linear road, which requires biotech company research. Stem cell biotech companies including publicly traded companies are an integral part of the field making that journey. How those […]
Tale of 7 stem cell biotech stock woes Read More »
Both current and former professional sports stars are lining up to get stem cell “treatments” of various kinds for all sorts of injuries and medical conditions including now Bart Starr. The aging stars who have received stem cell interventions include former San Francisco 49ers quarterback John Brodie (age 79) and more recently hockey legend, Gordie
More info on Bart Starr unproven clinic stem cell treatment Read More »
What countries are doing disproportionately well given their size on their stem cell research? When reading through the ISSCR 2015 program you can understand why everyone wants to go to the US for their postdoc as it seems like most of the work being presented is US-based. In fact, this is more than true with
What countries are ‘punching above their weight’ in stem cell space? Read More »
One of the biggest issues in the world of cellular medicine and also in cellular research is one of mistaken identity. I’m talking about scientists, doctors, or others thinking that their cells are one type (say type X) when in reality the cells are something else (say type Y). Or maybe the cells are some mixture
Stem cell mistaken identity: who are you? Read More »
For years I’ve been writing about fat stem cell clinics that sell non-FDA approved stem cell “treatments” to vulnerable patients right here in America. These clinics have been sprouting up like mushrooms across the US and their numbers may be above 200 today overall. As a result perhaps it was inevitable that one would arrive in
My new ‘neighbor’ in Sacramento: a fat stem cell clinic Read More »
Below is a list of upcoming stem cell and regenerative medicine conferences and meetings for 2016. If you do not see your meeting, please let me know and I will include it. This list is meant to be as inclusive as possible, but by listing specific events I am not necessarily endorsing them. January Molecular
Stem Cell Meetings & Conferences 2016 Read More »
There are a whole bunch of wonderful stem cell meetings, conferences, and courses remaining in the second half of 2015. If you are organizing (or just know of) another one and don’t see it listed here please let me know and I’ll add it in. I’m starting to collect those for 2016 as well so
Super stem cells meetings, & courses remaining in 2015 Read More »
Each year towards the end of December I make predictions for the coming year as I did for 2015. In the past I usually make a top 10 prediction list, but for this year I made 20 predictions. Admittedly some of them may have been more hopes than predictions. At mid-year today on June 30th,
How are my 20 stem cell predictions for 2015 doing? Read More »
What’s on your mind on this Monday morning and are you caffeinated enough yet? Depending on where you live it may even be time for dinner, bed, or already early Tuesday. Here are some Monday musings… To get safe and effective stem cell treatments to patients in a responsible, compliant manner you need commercial efforts
Monday morning musings: stocks, ISSCR, grants, CRISPR, New Book Read More »
The path to the clinic is a slow and arduous activity, frustrating not only to the researcher and patient, but investors and biotech companies. Successful clinical translation of technologies requires a balance of science, streamlined translation and funding. To develop fantastic science and then realise the most important components cannot be adapted to the clinical
Biotech Talks #ISSCR2015: StemCells Inc, Semma, ViaCyte, & Le Blanc Read More »